INCYTE CORPORATION Investing Cash Flow
INCYTE CORPORATION (INCY) reported Investing Cash Flow of -$88.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-04-28
- INCYTE CORPORATION net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$88.20M, a 8140.38% decline year-over-year.
- INCYTE CORPORATION net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$37.42M.
- INCYTE CORPORATION net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$47.42M, a 223.89% decline year-over-year.
- INCYTE CORPORATION net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was -$18.87M, a 108.83% decline year-over-year.
- INCYTE CORPORATION net cash provided by (used in) investing activities for fiscal 2025 was -$102.61M, a 165.14% decline from fiscal 2024.
- INCYTE CORPORATION net cash provided by (used in) investing activities for fiscal 2024 was $157.52M.
- INCYTE CORPORATION net cash provided by (used in) investing activities for fiscal 2023 was -$207.68M.
- INCYTE CORPORATION net cash provided by (used in) investing activities for fiscal 2022 was -$78.54M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$88.20M 10-Q · filed 2026-04-28 | -$125.62M derived: sum of 2 quarters · filed 2026-04-28 | -$173.04M derived: sum of 3 quarters · filed 2026-04-28 | -$191.91M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | -$37.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$84.83M derived: sum of 2 quarters · filed 2026-02-10 | -$103.71M derived: sum of 3 quarters · filed 2026-02-10 | -$102.61M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$47.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$66.29M derived: sum of 2 quarters · filed 2025-10-28 | -$65.19M 10-Q · filed 2025-10-28 | -$86.66M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | -$18.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$17.77M 10-Q · filed 2025-07-29 | -$39.24M derived: sum of 3 quarters · filed 2026-04-28 | -$966.00K derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $1.10M 10-Q · filed 2026-04-28 | -$20.37M derived: sum of 2 quarters · filed 2026-04-28 | $17.91M derived: sum of 3 quarters · filed 2026-04-28 | $231.73M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$21.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $16.81M derived: sum of 2 quarters · filed 2026-02-10 | $230.63M derived: sum of 3 quarters · filed 2026-02-10 | $157.52M 10-K · filed 2026-02-10 |
| 2024-09-30 | $38.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $252.09M derived: sum of 2 quarters · filed 2025-10-28 | $178.98M 10-Q · filed 2025-10-28 | $24.48M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $213.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $140.71M 10-Q · filed 2025-07-29 | -$13.79M derived: sum of 3 quarters · filed 2026-02-10 | -$30.98M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | -$73.11M 10-Q · filed 2025-04-29 | -$227.61M derived: sum of 2 quarters · filed 2026-02-10 | -$244.80M derived: sum of 3 quarters · filed 2026-02-10 | -$252.23M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | -$154.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$171.69M derived: sum of 2 quarters · filed 2026-02-10 | -$179.12M derived: sum of 3 quarters · filed 2026-02-10 | -$207.68M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$17.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$24.62M derived: sum of 2 quarters · filed 2024-10-29 | -$53.18M 10-Q · filed 2024-10-29 | -$74.09M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | -$7.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$35.99M 10-Q · filed 2024-07-30 | -$56.90M derived: sum of 3 quarters · filed 2025-02-10 | -$85.30M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$28.56M 10-Q · filed 2024-04-30 | -$49.47M derived: sum of 2 quarters · filed 2025-02-10 | -$77.87M derived: sum of 3 quarters · filed 2025-02-10 | -$90.35M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | -$20.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$49.31M derived: sum of 2 quarters · filed 2025-02-10 | -$61.79M derived: sum of 3 quarters · filed 2025-02-10 | -$78.54M 10-K · filed 2025-02-10 |
| 2022-09-30 | -$28.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | -$40.88M derived: sum of 2 quarters · filed 2023-10-31 | -$57.63M 10-Q · filed 2023-10-31 | -$123.68M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | -$12.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$29.23M 10-Q · filed 2023-08-01 | -$95.28M derived: sum of 3 quarters · filed 2024-02-13 | -$128.03M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | -$16.75M 10-Q · filed 2023-05-02 | -$82.80M derived: sum of 2 quarters · filed 2024-02-13 | -$115.55M derived: sum of 3 quarters · filed 2024-02-13 | -$164.69M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$66.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$98.80M derived: sum of 2 quarters · filed 2024-02-13 | -$147.95M derived: sum of 3 quarters · filed 2024-02-13 | -$207.70M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$32.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$81.90M derived: sum of 2 quarters · filed 2022-11-01 | -$141.65M 10-Q · filed 2022-11-01 | -$244.38M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | -$49.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$108.90M 10-Q · filed 2022-08-02 | -$211.63M derived: sum of 3 quarters · filed 2023-02-07 | -$226.08M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | -$59.75M 10-Q · filed 2022-05-03 | -$162.48M derived: sum of 2 quarters · filed 2023-02-07 | -$176.94M derived: sum of 3 quarters · filed 2023-02-07 | -$220.19M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | -$102.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | -$117.18M derived: sum of 2 quarters · filed 2023-02-07 | -$160.44M derived: sum of 3 quarters · filed 2023-02-07 | -$269.00M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$14.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$57.71M derived: sum of 2 quarters · filed 2021-11-02 | -$166.27M 10-Q · filed 2021-11-02 | -$196.30M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | -$43.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$151.82M 10-Q · filed 2021-08-03 | -$181.85M derived: sum of 3 quarters · filed 2022-02-08 | -$169.56M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | -$108.56M 10-Q · filed 2021-05-04 | -$138.59M derived: sum of 2 quarters · filed 2022-02-08 | -$126.30M derived: sum of 3 quarters · filed 2022-02-08 | -$171.45M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | -$30.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | -$17.74M derived: sum of 2 quarters · filed 2022-02-08 | -$62.89M derived: sum of 3 quarters · filed 2022-02-08 | -$87.45M 10-K · filed 2022-02-08 |
| 2019-09-30 | $12.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$32.86M derived: sum of 2 quarters · filed 2020-11-05 | -$57.43M 10-Q · filed 2020-11-05 | -$93.52M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | -$45.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$69.71M 10-Q · filed 2020-08-04 | -$105.81M derived: sum of 3 quarters · filed 2021-02-09 | -$123.68M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$24.56M 10-Q · filed 2020-05-05 | -$60.66M derived: sum of 2 quarters · filed 2021-02-09 | -$78.54M derived: sum of 3 quarters · filed 2021-02-09 | -$82.46M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$36.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$53.97M derived: sum of 2 quarters · filed 2021-02-09 | -$57.90M derived: sum of 3 quarters · filed 2021-02-09 | -$86.42M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$17.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$21.80M derived: sum of 2 quarters · filed 2019-10-29 | -$50.33M 10-Q · filed 2019-10-29 | -$193.33M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | -$3.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$32.45M 10-Q · filed 2019-07-30 | -$175.45M derived: sum of 3 quarters · filed 2020-02-13 | -$206.29M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$28.53M 10-Q · filed 2019-04-30 | -$171.53M derived: sum of 2 quarters · filed 2020-02-13 | -$202.37M derived: sum of 3 quarters · filed 2020-02-13 | -$239.69M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$143.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$173.84M derived: sum of 2 quarters · filed 2020-02-13 | -$211.16M derived: sum of 3 quarters · filed 2020-02-13 | -$349.98M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$30.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$68.16M derived: sum of 2 quarters · filed 2018-10-30 | -$206.98M 10-Q · filed 2018-10-30 | -$242.99M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | -$37.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$176.14M 10-Q · filed 2018-07-31 | -$212.15M derived: sum of 3 quarters · filed 2019-02-14 | -$222.10M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$138.82M 10-Q · filed 2018-05-01 | -$174.83M derived: sum of 2 quarters · filed 2019-02-14 | -$184.78M derived: sum of 3 quarters · filed 2019-02-14 | |
| 2016-12-31 | -$36.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$45.96M derived: sum of 2 quarters · filed 2019-02-14 | -$232.49M 10-K · filed 2019-02-14 | |
| 2016-09-30 | -$9.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$196.48M 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | -$186.52M 10-Q · filed 2017-08-01 | |||
| 2015-12-31 | -$105.01M 10-K · filed 2018-02-15 | |||
| 2011-06-30 | -$545.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$521.00K 10-Q · filed 2011-07-28 | ||
| 2011-03-31 | $24.00K 10-Q · filed 2011-05-03 | |||
| 2010-06-30 | $9.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $16.19M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $6.52M 10-Q · filed 2011-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |